Structure based on 1bil

Ideal structure
Name: (2s)-2-[(2-amino-1,3-thiazol-4-yl)methyl]-n~1~-[(1s,2r,3r)-1-(cyclohexylmethyl)-2,3-dihydroxy-5-methylhexyl]-n~4~-[2-(dimethylamino)-2-oxoethyl]-n~4~-[(1s)-1-phenylethyl]butanediamide
Formula: C34 H53 N5 O5 S
Weight: 643.880
SMILES: "CC(C)C[CH](O)[CH](O)[CH](CC1CCCCC1)NC(=O)[CH](CC(=O)N(CC(=O)N(C)C)[CH](C)c2ccccc2)Cc3csc(N)n3"
Spacial conformation based on PDB 1bil
RESIDUE   0IU     98
CONECT      C1     4 N    H11  H12  H13 
CONECT      C2     4 N    H21  H22  H23 
CONECT      C      3 O    N    CA  
CONECT      O      1 C   
CONECT      N      3 C1   C2   C   
CONECT      N1     3 C3   CA   CB  
CONECT      C3     3 N1   O1   CN  
CONECT      O1     1 C3  
CONECT      CA     4 C    N1   HA2  HA3 
CONECT      CB     4 N1   CG2  CG   HB  
CONECT      CG2    4 CB   HG21 HG22 HG23
CONECT      CG     3 CB   CD1  CD2 
CONECT      CD1    3 CG   CE1  HD1 
CONECT      CD2    3 CG   CE2  HD2 
CONECT      CE1    3 CD1  CZ   HE1 
CONECT      CE2    3 CD2  CZ   HE2 
CONECT      CZ     3 CE1  CE2  HZ  
CONECT      C4     3 O2   CA1  N2  
CONECT      O2     1 C4  
CONECT      CA1    4 C4   CN   CB1  HA  
CONECT      CN     4 C3   CA1  HN2  HN3 
CONECT      CB1    4 CA1  CG1  HB1  HB2 
CONECT      CG1    3 CB1  CD21 ND1 
CONECT      CD21   3 CG1  SE2  HD21
CONECT      SE2    2 CD21 CE11
CONECT      CE11   3 SE2  ND1  NZ  
CONECT      ND1    2 CG1  CE11
CONECT      NZ     3 CE11 HNZ1 HNZ2
CONECT      C11    4 C21  O11  C12  H121
CONECT      C21    4 C11  C31  N2   H2  
CONECT      C31    4 C21  C1'  H31  H32 
CONECT      C1'    4 C31  C2'  C6'  H1' 
CONECT      C2'    4 C1'  C3'  H2'1 H2'2
CONECT      C3'    4 C2'  C4'  H3'1 H3'2
CONECT      C4'    4 C3'  C5'  H4'1 H4'2
CONECT      C5'    4 C4'  C6'  H5'1 H5'2
CONECT      C6'    4 C1'  C5'  H6'1 H6'2
CONECT      N2     3 C4   C21  HN22
CONECT      O11    2 C11  HO1 
CONECT      C12    4 C11  C22  O12  H122
CONECT      C22    4 C12  C32  H211 H221
CONECT      C32    4 C22  C41  C5   H3  
CONECT      C41    4 C32  H41  H42  H43 
CONECT      C5     4 C32  H51  H52  H53 
CONECT      O12    2 C12  HO11
CONECT      H11    1 C1  
CONECT      H12    1 C1  
CONECT      H13    1 C1  
CONECT      H21    1 C2  
CONECT      H22    1 C2  
CONECT      H23    1 C2  
CONECT      HA2    1 CA  
CONECT      HA3    1 CA  
CONECT      HB     1 CB  
CONECT      HG21   1 CG2 
CONECT      HG22   1 CG2 
CONECT      HG23   1 CG2 
CONECT      HD1    1 CD1 
CONECT      HD2    1 CD2 
CONECT      HE1    1 CE1 
CONECT      HE2    1 CE2 
CONECT      HZ     1 CZ  
CONECT      HA     1 CA1 
CONECT      HN2    1 CN  
CONECT      HN3    1 CN  
CONECT      HB1    1 CB1 
CONECT      HB2    1 CB1 
CONECT      HD21   1 CD21
CONECT      HNZ1   1 NZ  
CONECT      HNZ2   1 NZ  
CONECT      H121   1 C11 
CONECT      H2     1 C21 
CONECT      H31    1 C31 
CONECT      H32    1 C31 
CONECT      H1'    1 C1' 
CONECT      H2'1   1 C2' 
CONECT      H2'2   1 C2' 
CONECT      H3'1   1 C3' 
CONECT      H3'2   1 C3' 
CONECT      H4'1   1 C4' 
CONECT      H4'2   1 C4' 
CONECT      H5'1   1 C5' 
CONECT      H5'2   1 C5' 
CONECT      H6'1   1 C6' 
CONECT      H6'2   1 C6' 
CONECT      HN22   1 N2  
CONECT      HO1    1 O11 
CONECT      H122   1 C12 
CONECT      H211   1 C22 
CONECT      H221   1 C22 
CONECT      H3     1 C32 
CONECT      H41    1 C41 
CONECT      H42    1 C41 
CONECT      H43    1 C41 
CONECT      H51    1 C5  
CONECT      H52    1 C5  
CONECT      H53    1 C5  
CONECT      HO11   1 O12 
END   
HET    0IU             98
HETSYN     0IU P2-P3 butanediamide renin inhibitor (1)
HETNAM     0IU (2S)-2-[(2-amino-1,3-thiazol-4-yl)methyl]-N~1~-[(1S,2R,
HETNAM   2 0IU 3R)-1-(cyclohexylmethyl)-2,3-dihydroxy-5-methylhexyl]-N
HETNAM   3 0IU ~4~-[2-(d imethylamino)-2-oxoethyl]-N~4~-[(1S)-1-phenyl
HETNAM   4 0IU ethyl]butanediamide
FORMUL      0IU    C34 H53 N5 O5 S1

This OCA MONOMER page
uses Jmol, developed by the Jmol Development Team (color reference)
OCA© by Jaime Prilusky, 1996-2004,2006,2010,2014
Bioinformatics Unit
Weizmann Institute of Science